Liver-directed gene therapy shows preclinical efficacy for severe inherited metabolic disorder

Genespire, successful collaboration with researchers astatine the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), announced the work of preclinical information supporting the imaginable of its liver-directed immune-shielded lentiviral cistron therapy attack to dainty methylmalonic acidemia (MMA), a terrible inherited metabolic disorder.